Unlike numerous other cancers, mutations in the tumour suppressor p53 are rare at diagnosis in neuroblastoma, despite abnormalities in the p53 pathway occurring in close to 50% of relapsed neuroblastoma and contributing to chemotherapy resistance [24]. The gene discussed is TP53; the disease is neuroblastoma.